<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17-pathogens-08-00176">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gane</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Lawitz</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Pugatch</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Papatheodoridis</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Br√§u</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Pol</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Leroy</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Persico</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Moreno</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2017</year>
  <volume>377</volume>
  <fpage>1448</fpage>
  <lpage>1455</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1704053</pub-id>
  <pub-id pub-id-type="pmid">29020583</pub-id>
 </element-citation>
</ref>
